| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | recombination hotspot binding | 3.72e-06 | 2 | 39 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 8.05e-05 | 43 | 39 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 2.86e-04 | 13 | 39 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 6.91e-04 | 20 | 39 | 2 | GO:0042800 | |
| GeneOntologyBiologicalProcess | positive regulation of reciprocal meiotic recombination | 1.87e-05 | 4 | 37 | 2 | GO:0010845 | |
| GeneOntologyBiologicalProcess | regulation of reciprocal meiotic recombination | 1.87e-05 | 4 | 37 | 2 | GO:0010520 | |
| GeneOntologyCellularComponent | keratin filament | 2.56e-05 | 97 | 37 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 6.75e-04 | 227 | 37 | 4 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.17e-03 | 263 | 37 | 4 | GO:0045111 | |
| HumanPheno | Perifollicular hyperkeratosis | 3.99e-08 | 4 | 12 | 3 | HP:0007468 | |
| HumanPheno | Abnormal perifollicular morphology | 1.99e-07 | 6 | 12 | 3 | HP:0031285 | |
| HumanPheno | Patchy alopecia | 2.52e-05 | 26 | 12 | 3 | HP:0002232 | |
| HumanPheno | Slow-growing hair | 3.53e-05 | 29 | 12 | 3 | HP:0002217 | |
| HumanPheno | Abnormality of hair growth rate | 3.53e-05 | 29 | 12 | 3 | HP:0011363 | |
| HumanPheno | Follicular hyperkeratosis | 3.91e-05 | 30 | 12 | 3 | HP:0007502 | |
| HumanPheno | Abnormality of hair growth | 3.91e-05 | 30 | 12 | 3 | HP:0040170 | |
| HumanPheno | Keratosis pilaris | 7.42e-05 | 37 | 12 | 3 | HP:0032152 | |
| HumanPheno | Acquired abnormal hair pattern | 1.25e-04 | 44 | 12 | 3 | HP:0011360 | |
| HumanPheno | Brittle hair | 2.32e-04 | 54 | 12 | 3 | HP:0002299 | |
| HumanPheno | Nail dystrophy | 3.46e-04 | 156 | 12 | 4 | HP:0008404 | |
| Domain | zf-nanos | 1.27e-05 | 3 | 39 | 2 | PF05741 | |
| Domain | Nanos/Xcar2 | 1.27e-05 | 3 | 39 | 2 | IPR008705 | |
| Domain | Znf_nanos-typ | 1.27e-05 | 3 | 39 | 2 | IPR024161 | |
| Domain | ZF_NANOS | 1.27e-05 | 3 | 39 | 2 | PS51522 | |
| Domain | Keratin_2_head | 1.65e-05 | 24 | 39 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 1.65e-05 | 24 | 39 | 3 | PF16208 | |
| Domain | Keratin_II | 2.12e-05 | 26 | 39 | 3 | IPR003054 | |
| Domain | SSXRD | 1.18e-04 | 8 | 39 | 2 | PF09514 | |
| Domain | SSXRD_motif | 1.18e-04 | 8 | 39 | 2 | IPR019041 | |
| Domain | KRAB_RELATED | 2.31e-04 | 11 | 39 | 2 | PS50806 | |
| Domain | Intermediate_filament_CS | 3.07e-04 | 63 | 39 | 3 | IPR018039 | |
| Domain | Krueppel-associated_box-rel | 3.27e-04 | 13 | 39 | 2 | IPR003655 | |
| Domain | Filament | 4.36e-04 | 71 | 39 | 3 | SM01391 | |
| Domain | IF | 4.54e-04 | 72 | 39 | 3 | PS00226 | |
| Domain | Filament | 4.73e-04 | 73 | 39 | 3 | PF00038 | |
| Domain | IF | 5.33e-04 | 76 | 39 | 3 | IPR001664 | |
| Domain | ZINC_FINGER_C2H2_2 | 9.93e-04 | 775 | 39 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.01e-03 | 777 | 39 | 7 | PS00028 | |
| Domain | Znf_C2H2 | 1.24e-03 | 805 | 39 | 7 | IPR007087 | |
| Domain | SET | 4.15e-03 | 46 | 39 | 2 | SM00317 | |
| Domain | Growth_fac_rcpt_ | 4.19e-03 | 156 | 39 | 3 | IPR009030 | |
| Domain | CUB | 4.70e-03 | 49 | 39 | 2 | PF00431 | |
| Domain | SET_dom | 4.89e-03 | 50 | 39 | 2 | IPR001214 | |
| Domain | CUB | 4.89e-03 | 50 | 39 | 2 | SM00042 | |
| Domain | SET | 4.89e-03 | 50 | 39 | 2 | PS50280 | |
| Domain | - | 5.27e-03 | 52 | 39 | 2 | 2.60.120.290 | |
| Domain | CUB | 5.47e-03 | 53 | 39 | 2 | PS01180 | |
| Domain | ZnF_C2H2 | 6.19e-03 | 808 | 39 | 6 | SM00355 | |
| Domain | CUB_dom | 6.31e-03 | 57 | 39 | 2 | IPR000859 | |
| Pathway | REACTOME_KERATINIZATION | 1.41e-04 | 153 | 25 | 4 | MM15343 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 4.73e-04 | 87 | 25 | 3 | MM15351 | |
| Pathway | REACTOME_KERATINIZATION | 5.36e-04 | 217 | 25 | 4 | M27640 | |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.41e-09 | 3 | 40 | 3 | 25557232 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.41e-09 | 3 | 40 | 3 | 1372089 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 1712823 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 15797458 | ||
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 3.08e-07 | 12 | 40 | 3 | 10692104 | |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 7.81e-07 | 16 | 40 | 3 | 15085952 | |
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 1.29e-06 | 2 | 40 | 2 | 15744029 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9665406 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9402962 | ||
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 1.35e-06 | 19 | 40 | 3 | 21285247 | |
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 3.87e-06 | 3 | 40 | 2 | 9084137 | |
| Pubmed | Sequence data and chromosomal localization of human type I and type II hair keratin genes. | 3.87e-06 | 3 | 40 | 2 | 7556444 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 9457912 | ||
| Pubmed | Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. | 7.73e-06 | 4 | 40 | 2 | 18231586 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 24736845 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 10668202 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 14675547 | ||
| Pubmed | 5.33e-05 | 63 | 40 | 3 | 16831889 | ||
| Pubmed | 7.05e-05 | 11 | 40 | 2 | 26609159 | ||
| Pubmed | 7.31e-05 | 70 | 40 | 3 | 34255829 | ||
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 1.53e-04 | 16 | 40 | 2 | 12399393 | |
| Pubmed | 1.87e-04 | 96 | 40 | 3 | 23580065 | ||
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 27234308 | ||
| Cytoband | 12q13 | 3.36e-05 | 71 | 40 | 3 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.45e-03 | 564 | 40 | 4 | chr11p15 | |
| GeneFamily | Keratins, type II | 4.49e-06 | 27 | 22 | 3 | 609 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.66e-04 | 718 | 22 | 6 | 28 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 1.68e-04 | 16 | 22 | 2 | 66 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.90e-04 | 17 | 22 | 2 | 1197 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.01e-07 | 182 | 40 | 5 | feda21c92d30848de70c8b404eaabbca3f5e894d | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 163 | 40 | 4 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 168 | 40 | 4 | 2765d98f0b7f6861d662937535e051d41dba3500 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-05 | 181 | 40 | 4 | ee1c5af8ed75dd8a0ed3152ba5b9a42d2a8c2ae4 | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 2.40e-05 | 188 | 40 | 4 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 2.40e-05 | 188 | 40 | 4 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | distal-Hematologic-Natural_Killer_T-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-05 | 196 | 40 | 4 | 05d2a15ba702b07ef59c55891a06da02cdd15f7f | |
| ToppCell | distal-Hematologic-Natural_Killer_T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.88e-05 | 197 | 40 | 4 | 5cb1b45f5dc8fbd9e54db9c943450ce2cc7000e4 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-05 | 199 | 40 | 4 | 3bac69726153e988a7f36613ee280c74d2fa7545 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.00e-05 | 67 | 40 | 3 | b80bdd122a0284611161c40ec7a9c893dc8de4de | |
| ToppCell | Sigmoid-(3)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 3.05e-05 | 200 | 40 | 4 | a7326c43987a5eb4f4f5b48c4252cf4870432e5d | |
| ToppCell | Sigmoid-(3)_ILC-(30)_ILC|Sigmoid / shred on region, Cell_type, and subtype | 3.05e-05 | 200 | 40 | 4 | c39de94623383da7b2b260eb016ddaa5da7f4350 | |
| ToppCell | Sigmoid-ILC-ILC|Sigmoid / Region, Cell class and subclass | 3.05e-05 | 200 | 40 | 4 | 4ac1e6d7f358003e2448eb69e545772cd261c55f | |
| ToppCell | Sigmoid-ILC|Sigmoid / Region, Cell class and subclass | 3.05e-05 | 200 | 40 | 4 | dfb06821f1019833f5d81f9c93808219b5fef407 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 104 | 40 | 3 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.09e-04 | 147 | 40 | 3 | 551c249f921ee0e70208abe207f2044d234d1ddc | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-04 | 148 | 40 | 3 | 99536d36c2ab5fac92765dac4fd8827a9368b181 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-04 | 150 | 40 | 3 | 580ed7733857402345f43ca2623f72cdd1edf22c | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.41e-04 | 152 | 40 | 3 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-04 | 153 | 40 | 3 | 0b3b199678d4a70b0590393568c69454bece5c14 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-04 | 153 | 40 | 3 | 5fb7d92cddc816c64071465e955ed0ea3bb45316 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-04 | 154 | 40 | 3 | 8dc8f02534c3ebda30bf9e702e36d0c53d89e5a5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.61e-04 | 155 | 40 | 3 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 156 | 40 | 3 | a1b9e7621b646d354c2ccd850ce6a4fa9ff8a026 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK_CD56bright|Leuk-UTI / Disease, Lineage and Cell Type | 3.75e-04 | 157 | 40 | 3 | db0057741d06e212a9543cb4b011659b79efeafc | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-04 | 158 | 40 | 3 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK_CD56bright|ICU-SEP / Disease, Lineage and Cell Type | 3.82e-04 | 158 | 40 | 3 | 53a942cdab4a3c6813dbe11368135a24b8de1880 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.82e-04 | 158 | 40 | 3 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-ILC3|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-04 | 161 | 40 | 3 | 584e44e6048c2678eb72cd23a86f48f2466c5da4 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-04 | 162 | 40 | 3 | 74cd0de957fdbe527656befd61f67d6814ce9e98 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.18e-04 | 163 | 40 | 3 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.18e-04 | 163 | 40 | 3 | 004765e016c5658ee4a8bda4899804303064727b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.18e-04 | 163 | 40 | 3 | 00e791358a7eb6c3e95f87afe22153845012e4a1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.18e-04 | 163 | 40 | 3 | 8a4931c9fdaedcf6c319157821d3556cd25fc9e5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.25e-04 | 164 | 40 | 3 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 4.25e-04 | 164 | 40 | 3 | 36e64e4f717dd59b352c20ff9742ca1e232342bb | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 4.41e-04 | 166 | 40 | 3 | ba42349a68b22e91a0340bda1ccecd6c7592392f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-04 | 166 | 40 | 3 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-04 | 166 | 40 | 3 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-04 | 166 | 40 | 3 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-04 | 166 | 40 | 3 | 62523e635784512b3261b672beaa7747cb9d114a | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Lung / Manually curated celltypes from each tissue | 4.49e-04 | 167 | 40 | 3 | dcbcc658082910838c8082d71a64917055086cc4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.56e-04 | 168 | 40 | 3 | b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-04 | 169 | 40 | 3 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.72e-04 | 170 | 40 | 3 | ce79f5d0d475fcb6c5a61c94938c65210b3c59d9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.72e-04 | 170 | 40 | 3 | aaf29c2d4de172d366cbfc863bc741941667dde1 | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|World / disease group, cell group and cell class | 4.72e-04 | 170 | 40 | 3 | caa6a534c1e9639caced9a51680f5c905f061bcc | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.89e-04 | 172 | 40 | 3 | 980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 4.97e-04 | 173 | 40 | 3 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|COVID-19_Moderate / disease group, cell group and cell class | 4.97e-04 | 173 | 40 | 3 | a07dcb1e555caaa2235aec219334fcbf2d07f10c | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-04 | 173 | 40 | 3 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 175 | 40 | 3 | 8727252bcbc70bfa2ff72e7421df9cfe6fd4eed7 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 175 | 40 | 3 | b8995e7ada85ba959f06264a0295b61e390c4e6c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-04 | 175 | 40 | 3 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-stromal_related-T_reticular|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 175 | 40 | 3 | 7ae76bd3b4f610b2f98716a4456437cd3696b686 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 175 | 40 | 3 | c083abe368e5c0dc2b0f27f375c9271a2d7ff64f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-04 | 176 | 40 | 3 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.31e-04 | 177 | 40 | 3 | fcdd71e2a727ae24b726a39216ea02c06df1f593 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 177 | 40 | 3 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 5.49e-04 | 179 | 40 | 3 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | Healthy_Control-Lymphoid-T-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.49e-04 | 179 | 40 | 3 | 4cd0bb3a99f85ff599b4b79a6a9ace3e51f8b296 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-04 | 179 | 40 | 3 | 9af894dfbe44e9706f5d178769ceda3b4e2d89c0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-04 | 179 | 40 | 3 | e717c0079b788a3703c0a450922bd5a2bdc322a0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-04 | 179 | 40 | 3 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-04 | 180 | 40 | 3 | 27672ac6a02172a31851f18decb9acffa8f5a703 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-04 | 180 | 40 | 3 | 512c005567ad9c78cc5cc83862fc1219bcf49f60 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-04 | 180 | 40 | 3 | ca7c316027e31559103b2cab1a2c0de993e42e95 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-04 | 180 | 40 | 3 | eb26ba86fba26899e54c448afc25382ddc853013 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-MAIT-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.58e-04 | 180 | 40 | 3 | 163c34783f013b3904ae2d43b7edde4d55a3e2e5 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.58e-04 | 180 | 40 | 3 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-MAIT|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.58e-04 | 180 | 40 | 3 | 12cd0b1c8cdf4b11f057657e2196c20ed54d222a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.67e-04 | 181 | 40 | 3 | a7f0a83e4f48eca8e753bda13c744cf41359fcc0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.6.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.67e-04 | 181 | 40 | 3 | e8c715fa3a0fed43ad4788b2d06cf45ab2c9e202 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.76e-04 | 182 | 40 | 3 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.76e-04 | 182 | 40 | 3 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-04 | 183 | 40 | 3 | 2c0b1265af2bca2c378ff7104bce337c98053b5e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-04 | 183 | 40 | 3 | d4a558bc0b8e11be195a7da1468ab38eb477117d | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.85e-04 | 183 | 40 | 3 | 797eb968c57e48db33ff8e2236ee22e9425c4676 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-04 | 184 | 40 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.95e-04 | 184 | 40 | 3 | e04cabff33a8e36967622ec3e5b37b89afa7e148 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_bright-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.04e-04 | 185 | 40 | 3 | 3b2da51aec057b462749ae39afb8f253afcf38d5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-04 | 185 | 40 | 3 | e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf | |
| ToppCell | IIH-NK|IIH / Condition, Cell_class and T cell subcluster | 6.14e-04 | 186 | 40 | 3 | cab1249b849013cf0334f25ee8d840f0521f4eb8 | |
| ToppCell | IIH-NK-|IIH / Condition, Cell_class and T cell subcluster | 6.14e-04 | 186 | 40 | 3 | 2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.23e-04 | 187 | 40 | 3 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.23e-04 | 187 | 40 | 3 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-04 | 188 | 40 | 3 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.43e-04 | 189 | 40 | 3 | 24519fa45e7d1c2fb397e9ffe00ecb7f7d4cefd8 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-04 | 189 | 40 | 3 | 5c85656f555d91ecc9540faa67717694a4aef92f | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 189 | 40 | 3 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.43e-04 | 189 | 40 | 3 | 723c57f278919e8251d56b3d19411f9088319450 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.43e-04 | 189 | 40 | 3 | 960374f5fb278659500a7c948c3068a95dd62eb0 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 189 | 40 | 3 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-04 | 190 | 40 | 3 | af39d2a46d9502cec69a69b7e8ffef78fc8311c3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.53e-04 | 190 | 40 | 3 | a8d92645950715d2621bf0064b1b2bb4eb400cb3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.53e-04 | 190 | 40 | 3 | ce049630ed69d31f00acbc1b5b0896efc592121f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 190 | 40 | 3 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-CD56bright_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.53e-04 | 190 | 40 | 3 | c8031df82c3662ce4140c850277987f7210e9bcd | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 6.63e-04 | 191 | 40 | 3 | 12ce360dc149c85d5a22cfc1bf53d54aef79edc1 | |
| ToppCell | MS-NK|MS / Condition, Cell_class and T cell subcluster | 6.73e-04 | 192 | 40 | 3 | f44f5dd30db169fdd16c9d706d17ad44907a17af | |
| Drug | 3,5-di-O-galloylquinic acid | 2.86e-06 | 2 | 39 | 2 | CID000460896 | |
| Drug | melicopicine | 2.86e-06 | 2 | 39 | 2 | CID000101253 | |
| Drug | tebuquine | 2.86e-06 | 2 | 39 | 2 | CID000071991 | |
| Drug | AC1L1BIT | 3.34e-06 | 60 | 39 | 4 | CID000001457 | |
| Drug | ATBI | 3.72e-06 | 18 | 39 | 3 | CID000505862 | |
| Drug | pyriproxyfen | 8.04e-06 | 23 | 39 | 3 | CID000091753 | |
| Drug | sulfonamide-3 | 8.57e-06 | 3 | 39 | 2 | CID009847197 | |
| Drug | U-37883A | 1.65e-05 | 29 | 39 | 3 | CID000064392 | |
| Drug | AC1L9HIO | 1.71e-05 | 4 | 39 | 2 | CID000445158 | |
| Drug | lactucin | 1.71e-05 | 4 | 39 | 2 | CID000442266 | |
| Drug | Lactupicrin | 1.71e-05 | 4 | 39 | 2 | CID000174880 | |
| Drug | diaspirin | 2.68e-05 | 34 | 39 | 3 | CID000065042 | |
| Drug | audouine | 2.85e-05 | 5 | 39 | 2 | CID000042787 | |
| Drug | skimmianine | 4.27e-05 | 6 | 39 | 2 | CID000006760 | |
| Drug | N-nitroso-L-arginine | 4.27e-05 | 6 | 39 | 2 | CID000127762 | |
| Drug | dictamnine | 4.27e-05 | 6 | 39 | 2 | CID000068085 | |
| Drug | NapNa | 4.27e-05 | 6 | 39 | 2 | CID000128726 | |
| Drug | arborinine | 4.27e-05 | 6 | 39 | 2 | CID005281832 | |
| Drug | nitrosonium | 5.86e-05 | 44 | 39 | 3 | CID000084878 | |
| Drug | pramiracetam | 5.97e-05 | 7 | 39 | 2 | CID000051711 | |
| Drug | DAF-FM DA | 5.97e-05 | 7 | 39 | 2 | CID002762646 | |
| Drug | TGQA | 5.97e-05 | 7 | 39 | 2 | CID000127406 | |
| Drug | AC1NLRUC | 5.97e-05 | 7 | 39 | 2 | CID004988604 | |
| Drug | desethylchloroquine | 7.95e-05 | 8 | 39 | 2 | CID000095478 | |
| Drug | AC1MBZ3X | 1.02e-04 | 9 | 39 | 2 | CID000004180 | |
| Drug | 1,1-dimethylguanidine | 1.02e-04 | 9 | 39 | 2 | CID000014461 | |
| Drug | bisdesethylchloroquine | 1.02e-04 | 9 | 39 | 2 | CID000122672 | |
| Drug | Vi-o | 1.02e-04 | 9 | 39 | 2 | CID005289554 | |
| Drug | DE gel | 1.03e-04 | 143 | 39 | 4 | CID000008146 | |
| Drug | guanidinoglutaric acid | 1.56e-04 | 11 | 39 | 2 | CID000002105 | |
| Drug | 8-amino-2-methylquinoline | 1.56e-04 | 11 | 39 | 2 | CID000140457 | |
| Drug | cetraxate | 1.56e-04 | 11 | 39 | 2 | CID000002680 | |
| Drug | al-Badry | 1.79e-04 | 165 | 39 | 4 | CID000004545 | |
| Drug | FAH2 | 1.80e-04 | 64 | 39 | 3 | CID000000661 | |
| Drug | thaliporphine | 1.87e-04 | 12 | 39 | 2 | CID000100020 | |
| Drug | B-H-H | 1.87e-04 | 12 | 39 | 2 | CID000447030 | |
| Drug | salsalate | 1.97e-04 | 66 | 39 | 3 | CID000005161 | |
| Drug | trioxane | 2.20e-04 | 13 | 39 | 2 | CID000008081 | |
| Drug | arteether | 2.20e-04 | 13 | 39 | 2 | CID000072416 | |
| Drug | Tiron | 2.25e-04 | 69 | 39 | 3 | CID000009001 | |
| Drug | AC1L9T0X | 2.57e-04 | 14 | 39 | 2 | CID000500472 | |
| Drug | Hb 7 | 2.57e-04 | 14 | 39 | 2 | CID000128180 | |
| Drug | GEA 3162 | 2.57e-04 | 14 | 39 | 2 | CID003035443 | |
| Drug | T6-7 | 2.57e-04 | 14 | 39 | 2 | CID000216324 | |
| Drug | DPTA-nonoate | 2.57e-04 | 14 | 39 | 2 | CID000177840 | |
| Drug | NG-amino-L-arginine | 2.57e-04 | 14 | 39 | 2 | CID000124357 | |
| Drug | AMT hydrochloride | 2.57e-04 | 14 | 39 | 2 | CID000001534 | |
| Drug | 2'-phosphoadenosine 5'-phosphate | 2.66e-04 | 73 | 39 | 3 | CID000002027 | |
| Drug | butyrate | 2.88e-04 | 767 | 39 | 7 | CID000000264 | |
| Drug | CP-9 | 2.96e-04 | 15 | 39 | 2 | CID000452634 | |
| Drug | l956 | 2.96e-04 | 15 | 39 | 2 | CID000017814 | |
| Drug | ferutinin | 3.38e-04 | 16 | 39 | 2 | CID000354654 | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 5394_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 3308_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; HL60; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6127_UP | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 6794_UP | |
| Drug | AC1NS0C1 | 3.83e-04 | 17 | 39 | 2 | CID005326326 | |
| Drug | naBE | 3.83e-04 | 17 | 39 | 2 | CID000151475 | |
| Drug | camonagrel | 3.83e-04 | 17 | 39 | 2 | CID000065892 | |
| Drug | S-methylisothiourea | 3.83e-04 | 17 | 39 | 2 | CID000005142 | |
| Drug | CQ-S | 3.83e-04 | 17 | 39 | 2 | CID000072462 | |
| Drug | 2,3-diaminonaphthalene | 4.30e-04 | 18 | 39 | 2 | CID000069872 | |
| Drug | sulfadoxine-pyrimethamine | 4.30e-04 | 18 | 39 | 2 | CID000065404 | |
| Drug | 1-TRIM | 4.30e-04 | 18 | 39 | 2 | CID000001359 | |
| Drug | AC1L191M | 4.77e-04 | 89 | 39 | 3 | CID000000350 | |
| Drug | NOC-7 | 4.80e-04 | 19 | 39 | 2 | CID000001383 | |
| Drug | cycloguanil | 5.33e-04 | 20 | 39 | 2 | CID000009048 | |
| Drug | NOC-5 | 5.33e-04 | 20 | 39 | 2 | CID000001625 | |
| Drug | artemether | 5.33e-04 | 20 | 39 | 2 | CID000068911 | |
| Drug | AC1L1KRE | 5.33e-04 | 20 | 39 | 2 | CID000005622 | |
| Drug | S-ethylisothiourea | 5.88e-04 | 21 | 39 | 2 | CID000005139 | |
| Drug | acetamidine | 5.88e-04 | 21 | 39 | 2 | CID000067171 | |
| Drug | 4-aminoquinoline | 5.88e-04 | 21 | 39 | 2 | CID000068476 | |
| Drug | DAF-FM | 6.46e-04 | 22 | 39 | 2 | CID010431792 | |
| Drug | AC1L1HCM | 6.46e-04 | 22 | 39 | 2 | CID000004072 | |
| Drug | DAF-2DA | 7.07e-04 | 23 | 39 | 2 | CID006603693 | |
| Drug | cilazaprilat | 7.07e-04 | 23 | 39 | 2 | CID000064766 | |
| Drug | AC1L1ICV | 7.07e-04 | 23 | 39 | 2 | CID000004522 | |
| Drug | AC1L1ICD | 7.07e-04 | 23 | 39 | 2 | CID000004516 | |
| Drug | PEG-SOD | 7.07e-04 | 23 | 39 | 2 | CID003086673 | |
| Drug | AC1L2K1Q | 7.07e-04 | 23 | 39 | 2 | CID000022258 | |
| Drug | hexamethylmelamine | 7.10e-04 | 102 | 39 | 3 | CID000002123 | |
| Drug | 2-phenylimidazole | 7.71e-04 | 24 | 39 | 2 | CID000069591 | |
| Drug | 4-phenylimidazole | 7.71e-04 | 24 | 39 | 2 | CID000069590 | |
| Drug | 28 N | 7.71e-04 | 24 | 39 | 2 | CID000004551 | |
| Drug | sulfadoxine | 7.71e-04 | 24 | 39 | 2 | CID000017134 | |
| Drug | 4,5-diaminofluorescein | 8.37e-04 | 25 | 39 | 2 | CID010666340 | |
| Drug | triflusal | 8.37e-04 | 25 | 39 | 2 | CID000009458 | |
| Drug | AC1NDMPA | 8.37e-04 | 25 | 39 | 2 | CID004628297 | |
| Drug | 4alpha-hydroxytetrahydrobiopterin | 8.37e-04 | 25 | 39 | 2 | CID000129803 | |
| Drug | pterin | 8.38e-04 | 108 | 39 | 3 | CID000073000 | |
| Drug | AC1NFHZ6 | 9.05e-04 | 26 | 39 | 2 | CID004683873 | |
| Drug | Septide | 9.05e-04 | 26 | 39 | 2 | CID000119137 | |
| Drug | oxyhyponitrite | 9.05e-04 | 26 | 39 | 2 | CID005491930 | |
| Drug | ONO-4007 | 9.05e-04 | 26 | 39 | 2 | CID006918241 | |
| Drug | heme b | 9.19e-04 | 444 | 39 | 5 | CID000004973 | |
| Drug | guanethidine | 9.55e-04 | 113 | 39 | 3 | CID000003518 | |
| Drug | hydroxyguanidine | 9.77e-04 | 27 | 39 | 2 | CID000080668 | |
| Disease | MONILETHRIX | 1.81e-09 | 3 | 37 | 3 | 158000 | |
| Disease | monilethrix (is_implicated_in) | 1.81e-09 | 3 | 37 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Beaded hair | 1.81e-09 | 3 | 37 | 3 | cv:C0546966 | |
| Disease | Monilethrix | 7.25e-09 | 4 | 37 | 3 | C0546966 | |
| Disease | hair disease (is_implicated_in) | 1.53e-06 | 2 | 37 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Central hypotonia | 2.29e-05 | 6 | 37 | 2 | C1842364 | |
| Disease | Myeloid Leukemia, Chronic | 6.08e-04 | 29 | 37 | 2 | C0023473 | |
| Disease | interleukin 2 measurement | 1.22e-03 | 41 | 37 | 2 | EFO_0008331 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.73e-03 | 49 | 37 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | idiopathic pulmonary fibrosis | 2.34e-03 | 57 | 37 | 2 | EFO_0000768 | |
| Disease | keratoconus | 3.12e-03 | 66 | 37 | 2 | MONDO_0015486 | |
| Disease | asthma, response to diisocyanate | 4.26e-03 | 261 | 37 | 3 | EFO_0006995, MONDO_0004979 | |
| Disease | Lung diseases | 4.33e-03 | 78 | 37 | 2 | C0024115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIAVYLIRFCCCRPP | 61 | Q9H313 | |
| MVCRPVFPCRRRFCP | 1 | A4D0V7 | |
| VFPCRRRFCPRPFLV | 6 | A4D0V7 | |
| RRFCPRPFLVGLVVA | 11 | A4D0V7 | |
| VRCCPVYFELRPVVE | 291 | Q13112 | |
| VPGYCERPLCPRLFR | 2506 | Q96M86 | |
| KVCPRCRYPVLRIEA | 91 | Q8N7E2 | |
| PLTGCLRYCTPRGRF | 86 | Q6P9G0 | |
| VRPLCKPRGICSRAY | 46 | Q9NXG6 | |
| GRVLCPILRDYVCPQ | 81 | P60323 | |
| PILRDYVCPQCGATR | 86 | P60323 | |
| CECLRRVFIYRQPAP | 511 | Q96RS6 | |
| RPYEPGIFCTRCGRR | 201 | Q4G1C9 | |
| RAARTPLCLVYCVRP | 96 | Q96EK9 | |
| RRLVCYCRLFEVPDP | 751 | Q6DN90 | |
| RPGRCCITAAPYRGI | 21 | O43790 | |
| RRYCPIPDVLCELGR | 556 | Q08426 | |
| DGRVLCPVLRRYTCP | 236 | Q8WY41 | |
| YECAPVKPFFCRIRG | 201 | P56645 | |
| LLRTVRCPCAVPYRD | 81 | Q7RTS6 | |
| CCRFSPPVRRLVRFL | 116 | Q96GM1 | |
| TCCSTRPRPRLYGIV | 186 | Q86SM5 | |
| YRTCRVIRPGCELLV | 341 | Q9NQV7 | |
| RRCCLRPGHYLVVPS | 491 | Q6ZSI9 | |
| RAGRTGICICFYQPR | 481 | Q9BQ39 | |
| YGTCDRGLRCVIRPP | 81 | Q9NZV1 | |
| ISYRPVSRPICRPIC | 391 | A8MUX0 | |
| RCIRCPVGTYQPEFG | 766 | Q9NQ36 | |
| RPSRCCITAAPYRGI | 26 | P78385 | |
| PGKREVVGYTIPCCR | 56 | Q6UXH9 | |
| VVIYVNSRPCCVPRV | 61 | Q8N983 | |
| YRTCRVIRPGCELLV | 341 | Q9NQW5 | |
| RVCLRHCIYTPQPGF | 276 | Q9BX79 | |
| KRPCFRVLPCYLERV | 96 | Q8WZ69 | |
| YICIVYPFRCVRPGK | 511 | Q9HBX9 | |
| YPFRCVRPGKCRTIT | 516 | Q9HBX9 | |
| FTIQGCYPVIRCLLR | 21 | Q9Y4R7 | |
| HSPQRVYLCPRCPRV | 3331 | Q96JG9 | |
| VIPARRPGFRVCYIC | 86 | Q6S9Z5 | |
| PARPRTVICYICGKE | 216 | Q6S9Z5 | |
| RPYQCPICRLRFTEA | 196 | Q96C55 | |
| VYGFVRACLRRLVPP | 461 | O14746 | |
| ERPYPCETCGKRFTR | 366 | Q8NAP8 | |
| RPGRCCITAAPYRGI | 21 | Q14533 | |
| VPVGVLRTPGLRCFY | 816 | Q8N9H8 |